Disease Progression, Resilience, and Inflammation Markers During the Coronavirus Disease 2019 Pandemic in Parkinson's Disease
Movement Disorders, 2022
Pauly C., Glaab E., Hansen M., Martin‐Gallausiaux C., Ledda M., Marques T., Wilmes P., Krüger R., Diederich N.,
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
Neurology | Patient Stratification | Serum |  Olink Target 96 |
Abstract
No abstract (research letter format).